Skip to main content
Clinical Trials/IRCT20170417033489N3
IRCT20170417033489N3CompletedPhase 3

The effect of LHRH agonist on the improvement of urinary retention compared with the effect of finasteride and tamsulosin alone

Mashhad University of Medical Sciences0 sites78 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
78

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
50 years to no limit (—)
Sex
Male

Inclusion Criteria

  • The first acute urinary retention
  • No other treatment
  • No indication of surgery
  • Patient's urinary retention is caused by BPH
  • Minimum age of 50 years

Exclusion Criteria

  • Informed patient dissatisfaction
  • History of any heart, liver, kidney, metabolic and seizure diseases
  • Patients with fever mean T more than 38 degrees Celsius
  • High PSA levels (above 4) which strengthen suspicion of prostate cancer

Investigators

Similar Trials

Completed
Not Applicable
The role of GnRH analogues (medical therapy) in improving fertility in women with early stage endometriosis.
CTRI/2016/08/007162AIIMS New Delhi90
Completed
Phase 3
Administering Gonadotrophin Releasing Hormone (GnRH) Agonists during the Luteal Phase in Artificial Cycle Frozen-Thawed Embryo TransfersFrozen Thawed embryo transfers in Assisted Reproduction TechnologyReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12614000715673Hopital Femme Mere Enfant220
Completed
Not Applicable
Treatment of infertility by intrauterine inseminatio
CTRI/2012/05/002682Employee state insurance post graduate institute of medicine and researchBASAIDARAPUR
Active, not recruiting
Not Applicable
Den endokrine effekt af enten r-LH eller lav dosis r-hCG tilskud til r-FSH stimulering hos normogonadotrope kvinder som gennemgår IVF/ICSI behandling efter en lang GnRH agonist nedreguleringsprotocol - Et prospektivt randomiseret kontrolleret ikke blindet pilot studieFertilitetsbehandling.Sammenligne de endokrine effekter, specielt E2 niveau på hCG dagen hos normogonadatrope IVF/ICSI patienter, som får tilskud af LH aktivitet i form af enten rhCG eller rLHMedDRA version: 9.1Level: LLTClassification code 10016398Term: Female infertility
EUCTR2009-009375-35-DKRegionshospital skive
Completed
Phase 2
Effects of GnRH agonist for luteal support on improvement of intracytoplasmic sperm injection cyclesoninflammatory disorders of female genital tract.Complication associated with artificial fertilization, unspecified
IRCT2016101729027N2Vice Chancellor for research of Shahid Beheshti University of Medical Sciences240